Introducing the HJF-MDC Venture Fund: Fostering Medical Innovations for Military and Civilian Applications dlvr.it/TL3Z4d

Cartesian Therapeutics Announces First Participant Enrolled in Phase 3 Trial of Descartes-08 for Myasthenia Gravis dlvr.it/TL4HDr

Virginia Business: GO Virginia grant boosts biotech in Roanoke, New River Valley dlvr.it/TL6xGp

Bizjournals: Virginia Tech seeks industry partners for Institute for Advanced Computing dlvr.it/TL74nY

Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine dlvr.it/TL7GhT

CoapTech Raises New Funding Round Led by Good Growth Capital dlvr.it/TL85rX

IonQ Completes Acquisition of Lightsynq, Accelerating Quantum Computing and Networking Roadmap dlvr.it/TL9GFz

Maryland Stem Cell Research Fund Announces Call for Applications for the July 2025 Cycle dlvr.it/TLBPVv

Welldoc Works with Lilly to Launch a New Personalized Health & Medicine Platform for Those Prescribed Lilly’s Incretin Therapies dlvr.it/TLBY78

USP announces new Advanced Technologies Laboratory in Maryland to accelerate and scale pharmaceutical manufacturing innovations dlvr.it/TLBkxt

REGENXBIO Shares Promising Early Results from Gene Therapy Trial for Duchenne Muscular Dystrophy dlvr.it/TLCTKn

GlycoMimetics Stockholders Approve Proposed Merger with Crescent Biopharma and All Related Proposals dlvr.it/TLCc9W

Previous BHCR Crab Trap Winner Luminoah Selected for Prestigious MedTech Innovator 2025 Accelerator Cohort dlvr.it/TLFqZM

IonQ Speeds Quantum-Accelerated Drug Development Application With AstraZeneca, AWS, and NVIDIA dlvr.it/TLFyBy

MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement dlvr.it/TLGvRY

Maryland's Governor Moore Announces $6.95 Million in ‘Build Our Future’ Grant Awards to Support Innovation Infrastructure Development dlvr.it/TLJ1Mk

MaxCyte and Ori Biotech Team Up to Streamline Autologous Cell Therapy Manufacturing dlvr.it/TLJ91W

Novavax’s Combo and Flu Vaccines Show Strong Immune Response in Early Phase 3 Trial dlvr.it/TLJLd0

anda Pharmaceuticals Doses First Patient in Trial for CMT Type 2S Treatment dlvr.it/TLJSgT

TEDCO Invests in NanoBioFAB dlvr.it/TLK6GL